SCHEMBL1668529

SCHEMBL1668529

CS(=O)(=O)N1CCN(c2ccc(OC3CN(Cc4ccc(C(F)(F)F)cc4)C3)c(F)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
PPARD Q03181 2/20 0.42
PPARA Q07869 2/20 0.42
EED O75530 1/20 0.42
NR1H2 P55055 5/20 0.42
NR1H3 Q13133 4/20 0.42
RORC P51449 3/20 0.41
SLC6A4 P31645 1/20 0.40
FPR1 P21462 1/20 0.39
FPR2 P25090 1/20 0.39
KCNH2 Q12809 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP2D6 P10635 1/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
SLC6A9 P48067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668235 0.89 KDM4E (0.53) KDM4EALDH1A1PPARDPPARAEED
SCHEMBL12198383 0.85 KDM4E (0.49) KDM4EALDH1A1PPARDPPARASLC6A4
SCHEMBL1668310 0.78 KDM4E (0.46) KDM4EALDH1A1PPARDPPARANR1H2
SCHEMBL1668232 0.77 KDM4E (0.53) KDM4EALDH1A1PPARDPPARAGPR119
SCHEMBL1668410 0.77 KDM4E (0.49) KDM4EALDH1A1NR1H2NR1H3RORC
SCHEMBL1670031 0.76 KDM4E (0.51) KDM4EALDH1A1PPARDPPARAGPR119
SCHEMBL1668538 0.76 KDM4E (0.51) KDM4EALDH1A1PPARDPPARAKCNH2
SCHEMBL1669073 0.74 PPARD (0.39) KDM4EALDH1A1PPARDPPARANR1H2
SCHEMBL12198260 0.73 KDM4E (0.48) KDM4EALDH1A1RORCKCNH2GPR119
SCHEMBL12198370 0.73 ALDH1A1 (0.51) KDM4EALDH1A1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US claimed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP claimed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US claimed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO claimed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP disclosed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US disclosed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 KDM4E 3454/4885ALDH1A1 2341/4885PPARD 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.